23 May 2013
Keywords: elan/biogen, idec, antegren, filed, crohn, disease, eu
Article | 04 October 2004
USA-based Biogen Idec and Ireland's Elan Corp have submitted a Marketing Authorization Application to the European Medicines Agency for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 October 2004
15 November 2004
8 November 2004
© 2013 thepharmaletter.com